250 related articles for article (PubMed ID: 31200008)
1. The case for oxidative stress molecule involvement in the tick-pathogen interactions -an omics approach.
Hernandez EP; Talactac MR; Fujisaki K; Tanaka T
Dev Comp Immunol; 2019 Nov; 100():103409. PubMed ID: 31200008
[TBL] [Abstract][Full Text] [Related]
2. Tick vaccines and the control of tick-borne pathogens.
Merino O; Alberdi P; Pérez de la Lastra JM; de la Fuente J
Front Cell Infect Microbiol; 2013; 3():30. PubMed ID: 23847771
[TBL] [Abstract][Full Text] [Related]
3. Microbial Invasion vs. Tick Immune Regulation.
Sonenshine DE; Macaluso KR
Front Cell Infect Microbiol; 2017; 7():390. PubMed ID: 28929088
[TBL] [Abstract][Full Text] [Related]
4. Tick immunobiology.
Brossard M; Wikel SK
Parasitology; 2004; 129 Suppl():S161-76. PubMed ID: 15940820
[TBL] [Abstract][Full Text] [Related]
5. Induced Transient Immune Tolerance in Ticks and Vertebrate Host: A Keystone of Tick-Borne Diseases?
Boulanger N; Wikel S
Front Immunol; 2021; 12():625993. PubMed ID: 33643313
[TBL] [Abstract][Full Text] [Related]
6. Tick Bioactive Molecules as Novel Therapeutics: Beyond Vaccine Targets.
Murfin KE; Fikrig E
Front Cell Infect Microbiol; 2017; 7():222. PubMed ID: 28634573
[No Abstract] [Full Text] [Related]
7. Characterization of the tick-pathogen interface by quantitative proteomics.
Villar M; Popara M; Bonzón-Kulichenko E; Ayllón N; Vázquez J; de la Fuente J
Ticks Tick Borne Dis; 2012 Jun; 3(3):154-8. PubMed ID: 22647712
[TBL] [Abstract][Full Text] [Related]
8. The tick endosymbiont Candidatus Midichloria mitochondrii and selenoproteins are essential for the growth of Rickettsia parkeri in the Gulf Coast tick vector.
Budachetri K; Kumar D; Crispell G; Beck C; Dasch G; Karim S
Microbiome; 2018 Aug; 6(1):141. PubMed ID: 30103809
[TBL] [Abstract][Full Text] [Related]
9. Interactomics and tick vaccine development: new directions for the control of tick-borne diseases.
Artigas-Jerónimo S; De La Fuente J; Villar M
Expert Rev Proteomics; 2018 Aug; 15(8):627-635. PubMed ID: 30067120
[TBL] [Abstract][Full Text] [Related]
10. Editorial: Tick-Host-Pathogen Interactions.
Bonnet SI; Nijhof AM; de la Fuente J
Front Cell Infect Microbiol; 2018; 8():194. PubMed ID: 29963500
[No Abstract] [Full Text] [Related]
11. Prevention and control strategies for ticks and pathogen transmission.
de La Fuente J; Kocan KM; Contreras M
Rev Sci Tech; 2015 Apr; 34(1):249-64. PubMed ID: 26470461
[TBL] [Abstract][Full Text] [Related]
12. Interaction of the tick immune system with transmitted pathogens.
Hajdušek O; Síma R; Ayllón N; Jalovecká M; Perner J; de la Fuente J; Kopáček P
Front Cell Infect Microbiol; 2013; 3():26. PubMed ID: 23875177
[TBL] [Abstract][Full Text] [Related]
13. How ticks keep ticking in the adversity of host immune reactions.
Jennings R; Kuang Y; Thieme HR; Wu J; Wu X
J Math Biol; 2019 Apr; 78(5):1331-1364. PubMed ID: 30478760
[TBL] [Abstract][Full Text] [Related]
14. Tick saliva in anti-tick immunity and pathogen transmission.
Kovár L
Folia Microbiol (Praha); 2004; 49(3):327-36. PubMed ID: 15259776
[TBL] [Abstract][Full Text] [Related]
15. A Roadmap for Tick-Borne Flavivirus Research in the "Omics" Era.
Grabowski JM; Hill CA
Front Cell Infect Microbiol; 2017; 7():519. PubMed ID: 29312896
[TBL] [Abstract][Full Text] [Related]
16. Serine Protease Inhibitors in Ticks: An Overview of Their Role in Tick Biology and Tick-Borne Pathogen Transmission.
Blisnick AA; Foulon T; Bonnet SI
Front Cell Infect Microbiol; 2017; 7():199. PubMed ID: 28589099
[TBL] [Abstract][Full Text] [Related]
17. Anti-tick and pathogen transmission blocking vaccines.
van Oosterwijk JG
Parasite Immunol; 2021 May; 43(5):e12831. PubMed ID: 33704804
[TBL] [Abstract][Full Text] [Related]
18. Tick-Pathogen Interactions and Vector Competence: Identification of Molecular Drivers for Tick-Borne Diseases.
de la Fuente J; Antunes S; Bonnet S; Cabezas-Cruz A; Domingos AG; Estrada-Peña A; Johnson N; Kocan KM; Mansfield KL; Nijhof AM; Papa A; Rudenko N; Villar M; Alberdi P; Torina A; Ayllón N; Vancova M; Golovchenko M; Grubhoffer L; Caracappa S; Fooks AR; Gortazar C; Rego ROM
Front Cell Infect Microbiol; 2017; 7():114. PubMed ID: 28439499
[TBL] [Abstract][Full Text] [Related]
19. [The probable utilization of the protective properties of the vector's saliva by the causative agents of specifically tick-borne infections].
Alekseev AN; Podboronov VM; Burenkova LA
Parazitologiia; 1995; 29(3):154-8. PubMed ID: 7567075
[TBL] [Abstract][Full Text] [Related]
20. Translational biotechnology for the control of ticks and tick-borne diseases.
de la Fuente J
Ticks Tick Borne Dis; 2021 Sep; 12(5):101738. PubMed ID: 34023540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
